All News

At the 14th Annual World Health Care Congress, held April 30-May 3, 2017, in Washington, DC, an executive summit convened a panel to discuss ways to improve care for the dual-eligible population of patients eligible for both Medicaid and Medicare benefits.

The American Society of Clinical Oncology (ASCO) and Representative Robin Kelly emphasize need to increase healthcare workforce diversity to improve patient outcomes.

Patients with irritable bowel syndrome with diarrhea (IBS-D) incur significantly more healthcare costs than matched controls. A new study in the Journal of Managed Care & Specialty Pharmacy found that the extra costs were associated with an increased use of medical services.

Molina Healthcare has announced a big leadership shakeup: the board of directors has ousted J. Mario Molina, MD, president and CEO, and John C. Molina, chief financial officer.

The group that represents a host of Fortune 500 employers said a faster shift to value-based care is needed to drive innovation and vitalize the economy.

The study's authors say the findings show the need to find the right balance between guarding against skin cancer and getting enough vitamin D.

State Medicaid directors who transitioned to the private sector told the GAO that the pay got better and the job got easier. They were no longer directly accountable to a governor, the legislature, or CMS, and they didn't have to manage 2 different delivery systems.

People with diabetes are particularly in need of regular eye exams to get for signs of diabetic retinopathy, which can lead to blindness.

Lawmakers averted the looming threat of a government shutdown when they forged a bipartisan deal to fund the government for the rest of the fiscal year, which ends October 2017. The agreement includes substantial funding boosts for key health initiatives.

Midostaurin (Rydapt) has been approved by the FDA, in combination with chemotherapy, for the treatment of adult patients newly diagnosed with acute myeloid leukemia (AML) with a mutation in the FLT3 gene.

Healthcare has the opportunity to not only improve connections between systems, but also find cost savings and productivity gains.

Saturday marks the 100th day of Donald Trump’s presidency, and closes out the time period during which a president’s power and influence are supposed to be greatest. As a result, the first 100 days are used to measure the successes and accomplishments of a new president.

In the first 100 days of his administration, President Donald J. Trump has taken a number of actions that could impact healthcare, including filling a Supreme Court seat and taking steps to repeal the Affordable Care Act. Here's a look back at some of the most notable healthcare-related happenings in Trump's first 100 days in office.

This week, the top managed care stories included President Donald Trump's nominee passing a Senate committee; community oncologists meet to discuss the Cancer Moonshot; and a study finds obesity shortens more lives than cigarettes.

When the ACO & Emerging Healthcare Delivery Coalition® meets May 4-5 in Scottsdale, Arizona, attendees will learn the latest on healthcare reform, best practices for cybersecurity, population health strategies, and more.

The report found that hospitals have little financial incentive to offer long-acting contraception right after birth if it is not covered separately. Family planning services are not part of standard quality measures, so it's hard to track how well providers are doing.

A new study has found that patients with early stage type 2 diabetes (T2D) are more likely to have structural abnormalities in the brain and cognitive difficulties, particularly if they are overweight or obese.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

While the report documents the shortage of DSME programs in rural areas, it does not address the reimbursement challenges that confront the use of telehealth to reach underserved groups.

The Senate Committee on Health, Education, Labor & Pensions voted 14-9 to approve the nomination of Scott Gottlieb, MD, to lead the FDA. He will now need to be confirmed by the full Senate to become FDA commissioner.

While there are many hurdles to overcome before the technology could be ready for commercial use, the experiment shows what could be possible for people living with diabetes.

Second primary malignant neoplasms (SPMs) are a well-known late effect after cancer, and a new study has found that they are more deadly among children and young adults than older adults.

The study from King's College of London is the latest to sound the alarm about rising incidence of type 2 diabetes among youth.